vs
Side-by-side financial comparison of COMERICA INC (CMA) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $838.0M, roughly 1.8× COMERICA INC). COMERICA INC runs the higher net margin — 21.0% vs -13.6%, a 34.6% gap on every dollar of revenue. On growth, COMERICA INC posted the faster year-over-year revenue change (3.3% vs -5.3%). Over the past eight quarters, COMERICA INC's revenue compounded faster (108.9% CAGR vs -3.6%).
Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
CMA vs OGN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $838.0M | $1.5B |
| Net Profit | $176.0M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | — | -9.8% |
| Net Margin | 21.0% | -13.6% |
| Revenue YoY | 3.3% | -5.3% |
| Net Profit YoY | -4.3% | -288.1% |
| EPS (diluted) | $1.35 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.5B | ||
| Q3 25 | $838.0M | $1.6B | ||
| Q2 25 | $849.0M | $1.6B | ||
| Q1 25 | $829.0M | $1.5B | ||
| Q4 24 | $825.0M | $1.6B | ||
| Q3 24 | $811.0M | $1.6B | ||
| Q2 24 | $824.0M | $1.6B | ||
| Q1 24 | $784.0M | $1.6B |
| Q4 25 | — | $-205.0M | ||
| Q3 25 | $176.0M | $160.0M | ||
| Q2 25 | $199.0M | $145.0M | ||
| Q1 25 | $172.0M | $87.0M | ||
| Q4 24 | $170.0M | $109.0M | ||
| Q3 24 | $184.0M | $359.0M | ||
| Q2 24 | $206.0M | $195.0M | ||
| Q1 24 | $138.0M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | — | -9.8% | ||
| Q3 25 | — | 15.2% | ||
| Q2 25 | — | 14.4% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 14.6% | ||
| Q1 24 | — | 14.5% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | 21.0% | 10.0% | ||
| Q2 25 | 23.4% | 9.1% | ||
| Q1 25 | 20.7% | 5.8% | ||
| Q4 24 | 20.6% | 6.8% | ||
| Q3 24 | 22.7% | 22.7% | ||
| Q2 24 | 25.0% | 12.1% | ||
| Q1 24 | 17.6% | 12.4% |
| Q4 25 | — | $-0.78 | ||
| Q3 25 | $1.35 | $0.61 | ||
| Q2 25 | $1.42 | $0.56 | ||
| Q1 25 | $1.25 | $0.33 | ||
| Q4 24 | $1.22 | $0.42 | ||
| Q3 24 | $1.33 | $1.38 | ||
| Q2 24 | $1.49 | $0.75 | ||
| Q1 24 | $0.98 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $574.0M |
| Total DebtLower is stronger | $5.4B | $8.6B |
| Stockholders' EquityBook value | $7.4B | $752.0M |
| Total Assets | $77.4B | $12.9B |
| Debt / EquityLower = less leverage | 0.73× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $574.0M | ||
| Q3 25 | — | $672.0M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $547.0M | ||
| Q4 24 | — | $675.0M | ||
| Q3 24 | — | $763.0M | ||
| Q2 24 | — | $704.0M | ||
| Q1 24 | — | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | $5.4B | $8.8B | ||
| Q2 25 | $5.8B | $8.9B | ||
| Q1 25 | $5.7B | $9.0B | ||
| Q4 24 | $6.7B | $8.9B | ||
| Q3 24 | $6.8B | $8.7B | ||
| Q2 24 | $7.1B | $8.7B | ||
| Q1 24 | $7.1B | $8.7B |
| Q4 25 | — | $752.0M | ||
| Q3 25 | $7.4B | $906.0M | ||
| Q2 25 | $6.9B | $733.0M | ||
| Q1 25 | $7.1B | $542.0M | ||
| Q4 24 | $6.5B | $472.0M | ||
| Q3 24 | $7.4B | $493.0M | ||
| Q2 24 | $6.2B | $144.0M | ||
| Q1 24 | $6.0B | $48.0M |
| Q4 25 | — | $12.9B | ||
| Q3 25 | $77.4B | $13.6B | ||
| Q2 25 | $78.0B | $13.5B | ||
| Q1 25 | $77.6B | $13.2B | ||
| Q4 24 | $79.3B | $13.1B | ||
| Q3 24 | $79.7B | $12.8B | ||
| Q2 24 | $79.6B | $12.2B | ||
| Q1 24 | $79.4B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | 0.73× | 9.74× | ||
| Q2 25 | 0.84× | 12.14× | ||
| Q1 25 | 0.81× | 16.52× | ||
| Q4 24 | 1.02× | 18.81× | ||
| Q3 24 | 0.92× | 17.75× | ||
| Q2 24 | 1.15× | 60.11× | ||
| Q1 24 | 1.18× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-270.0M | $141.0M |
| Free Cash FlowOCF − Capex | — | $96.0M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | -1.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $141.0M | ||
| Q3 25 | $-270.0M | $264.0M | ||
| Q2 25 | $476.0M | $220.0M | ||
| Q1 25 | $273.0M | $75.0M | ||
| Q4 24 | $601.0M | $390.0M | ||
| Q3 24 | $1.0B | $141.0M | ||
| Q2 24 | $111.0M | $332.0M | ||
| Q1 24 | $-205.0M | $76.0M |
| Q4 25 | — | $96.0M | ||
| Q3 25 | — | $218.0M | ||
| Q2 25 | — | $181.0M | ||
| Q1 25 | — | $43.0M | ||
| Q4 24 | — | $335.0M | ||
| Q3 24 | — | $99.0M | ||
| Q2 24 | — | $300.0M | ||
| Q1 24 | — | $30.0M |
| Q4 25 | — | 6.4% | ||
| Q3 25 | — | 13.6% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 21.0% | ||
| Q3 24 | — | 6.3% | ||
| Q2 24 | — | 18.7% | ||
| Q1 24 | — | 1.8% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | -1.53× | 1.65× | ||
| Q2 25 | 2.39× | 1.52× | ||
| Q1 25 | 1.59× | 0.86× | ||
| Q4 24 | 3.54× | 3.58× | ||
| Q3 24 | 5.70× | 0.39× | ||
| Q2 24 | 0.54× | 1.70× | ||
| Q1 24 | -1.49× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
